Amazon has broken down from a double top pattern and is testing key technical support zones, with downside risk increasing if support fails to hold.
Over recent months, a striking pattern has emerged: major capital allocators are positioning around AI-driven biology and longevity.
In what may be one of the more questionable uses of AI to date, Amazon announced on Wednesday that it will display AI-generated images of products within its shopping app based on users' search queries. That's right — a retailer where people shop for real-world products thinks that displaying fake photos will “help” consumers better find what they're looking for.
The artificial intelligence boom has created plenty of winners, but one company sits at the center of it all.
Amazon surpassed $700 billion in revenue in 2025 with a 12% year-over-year jump.
Amazon (NASDAQ:AMZN | AMZN Price Prediction) is a stock worth owning for decades because its three highest-margin engines (AWS, advertising, and subscriptions) are now compounding faster than its low-margin retail business, and that mix shift is structural.
On June 1, CNBC reported that Berkshire Hathaway (NYSE:BRK-B | BRK-B Price Prediction) invested an additional $10 billion in Alphabet (NASDAQ:GOOGL) through a private stock purchase, deepening its bet on artificial intelligence.
One fund leans into disruptive tech, while the other sticks to industry stalwarts-cost, volatility, and sector focus set them apart for investors.
The stock market is roaring, and according to the media, it's all because of AI.
As the big wave of mega AI IPOs moves in, the retail crowd is probably eager to punch their ticket.